Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

FIVP calls for change amid CMA consultation
FIVP says independent practices should use the investigation to prove their position as trusted partners in the sector.
The group encourages independent practices to consider the review as an opportunity.

The Federation of Independent Veterinary Practices (FIVP) has submitted a response to the Competition and Markets Authority (CMA), as the government department seeks to launch a market investigation.

In the response, published on its website, FIVP has called for optimism from independent practices, stating that the review provides an ‘opportunity’ for practices to improve standards of care and promote healthy competition.

The non-profit organisation, which represents independent veterinary practices across the country, has urged the CMA’s investigation to ensure clearer representation of ownership of practices. The CMA’s initial review found that four of the six corporate groups were not changing the branding of the independent practices they acquired.

Furthermore, FIVP has pressed for greater clarity of the ownership and incentives received for referrals to associated businesses, such as referrals centres and external cremation services.

Although FIVP states that the profit margins within independent practices have remained consistent in the past five years, it believes that better transparency of pricing across both corporate-owned and independent practices could facilitate fairer competition.

As well as pricing structures ahead of treatment, this would include the pricing of subsequent procedures, detailing different treatment levels rather than promoting that of the highest cost. The organisation reflects that this transparency could pose a challenge, considering a wide range of procedures, species and requirements.

The response additionally calls for a review of prescription fees, and better distinguished differences between prescribing and writing a prescription.

FIVP believes that the investigation will not only serve to ensure fairer competition and consumer protection within the veterinary industry, but also allows independent practices the opportunity to improve their own practices.

The organisation says that independent practices should use the CMA’s recommendations to prove their commitment to quality service provision and ethical practices.

The recommendations could also be used by the practices to evaluate their own operations and identify areas for improvement. FIVP believes this will better position independent practices as professional and trusted partners in the veterinary sector.

In its closing remarks, FIVP writes: “Overall, embracing the insights and recommendations of the CMA’s review can help independent veterinary practices navigate the evolving landscape of the sector, foster healthy competition, and ultimately contribute to the well-being of animals and pet owners.”

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.